SCHEMBL6499099

SCHEMBL6499099

Cc1cc(O)ccc1-c1ccc(-n2cc(NC(N)=O)c(C(N)=O)n2)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.42
ALDH1A1 P00352 3/20 0.39
NPC1 O15118 2/20 0.39
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
KDM4E B2RXH2 2/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
IRAK4 Q9NWZ3 4/20 0.35
ESR2 Q92731 3/20 0.34
ESR1 P03372 2/20 0.34
DDX3X O00571 1/20 0.34
CDK8 P49336 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B1 P14061 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6502483 0.91 ITK (0.41) ITKALDH1A1NPC1CA1CA2
SCHEMBL6468202 0.89 ITK (0.43) ITKALDH1A1NPC1CA1CA2
SCHEMBL6502100 0.88 SCN9A (0.45) ITKALDH1A1KDM4ESMN1; SMN2IRAK4
SCHEMBL6468674 0.88 ITK (0.43) ITKALDH1A1NPC1CA1CA2
SCHEMBL6470611 0.87 ITK (0.40) ITKALDH1A1NPC1CA1CA2
SCHEMBL6470704 0.85 ITK (0.39) ITKALDH1A1NPC1CA1CA2
SCHEMBL6502246 0.82 ITK (0.44) ITKALDH1A1NPC1CA1CA2
SCHEMBL6467605 0.82 ITK (0.44) ITKALDH1A1NPC1CA1CA2
SCHEMBL6506313 0.82 ITK (0.44) ITKALDH1A1NPC1CA1CA2
SCHEMBL6507365 0.82 ITK (0.38) ITKALDH1A1NPC1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ITK 4236/4885ALDH1A1 846/4885NPC1 3546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.